Lupus Drug Cuts Heart Disease Risk in 5-Year Study

Young and middle-aged Black women with discoid lupus just got hopeful news about protecting their hearts. A Johns Hopkins Medicine study shows that hydroxychloroquine, a drug already used for other forms of lupus, dramatically reduces the risk of heart disease and metabolic problems in people with this skin condition.

Discoid lupus causes disc-shaped plaques on the skin and primarily affects young to middle-aged Black women. Doctors have traditionally treated it as a skin-only problem, but recent research reveals it triggers systemic inflammation that puts hearts at risk.

Lead researcher Dr. Jun Kang and his team tracked over 4,600 patients with discoid lupus for five years. They compared those taking hydroxychloroquine to those who weren't using the medication.

The results were striking. Among Johns Hopkins patients, those taking hydroxychloroquine were far less likely to develop high cholesterol (23% versus 48%), peripheral artery disease (2% versus 17%), chest pain (3% versus 26%), and coronary artery disease (10% versus 26%).

A larger database of 4,520 patients confirmed the pattern. Hydroxychloroquine users showed lower rates of high blood pressure, high cholesterol, type 2 diabetes, stroke, and coronary artery disease compared to non-users.

The drug, originally developed to treat malaria, already helps patients with systemic lupus manage autoimmune symptoms. Now researchers believe it offers similar protection for people with the skin-limited form of the disease.

Why This Inspires

This research could transform how doctors approach discoid lupus treatment. For too long, patients received only topical creams focused on visible skin symptoms while invisible cardiovascular risks went unaddressed.

Dr. Kang's team is now working to identify which patients would benefit most from hydroxychloroquine as a first-line treatment. They hope to establish new guidelines that help doctors look beyond the skin and protect patients' overall health.

The breakthrough matters especially for Black women, who face both higher rates of discoid lupus and greater cardiovascular disease risks. Better treatment guidelines could close a critical gap in care.

Shifting how medicine views and treats skin lupus could save lives by preventing heart attacks, strokes, and diabetes before they develop.